These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 17057085)
41. An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection. Allenbach C; Launois P; Mueller C; Tacchini-Cottier F Eur J Immunol; 2008 Mar; 38(3):720-31. PubMed ID: 18266271 [TBL] [Abstract][Full Text] [Related]
42. Efficient control of Leishmania and Strongyloides despite partial suppression of nematode-induced Th2 response in co-infected mice. Kolbaum J; Ritter U; Zimara N; Brewig N; Eschbach ML; Breloer M Parasite Immunol; 2011 Apr; 33(4):226-35. PubMed ID: 21204851 [TBL] [Abstract][Full Text] [Related]
43. CCL2-independent role of CCR2 in immune responses against Leishmania major. Quinones MP; Estrada CA; Jimenez F; Martinez H; Willmon O; Kuziel WA; Ahuja SK; Ahuja SS Parasite Immunol; 2007 Apr; 29(4):211-7. PubMed ID: 17371458 [TBL] [Abstract][Full Text] [Related]
44. Co-infected C57BL/6 mice mount appropriately polarized and compartmentalized cytokine responses to Litomosoides sigmodontis and Leishmania major but disease progression is altered. Lamb TJ; Graham AL; Le Goff L; Allen JE Parasite Immunol; 2005 Sep; 27(9):317-24. PubMed ID: 16149989 [TBL] [Abstract][Full Text] [Related]
45. Overexpression of a single Leishmania major gene enhances parasite infectivity in vivo and in vitro. Reiling L; Chrobak M; Schmetz C; Clos J Mol Microbiol; 2010 Jun; 76(5):1175-90. PubMed ID: 20345655 [TBL] [Abstract][Full Text] [Related]
46. Wound healing response is a major contributor to the severity of cutaneous leishmaniasis in the ear model of infection. Baldwin T; Sakthianandeswaren A; Curtis JM; Kumar B; Smyth GK; Foote SJ; Handman E Parasite Immunol; 2007 Oct; 29(10):501-13. PubMed ID: 17883453 [TBL] [Abstract][Full Text] [Related]
47. Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies. Späth GF; Lye LF; Segawa H; Turco SJ; Beverley SM Infect Immun; 2004 Jun; 72(6):3622-7. PubMed ID: 15155672 [TBL] [Abstract][Full Text] [Related]
48. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice. Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365 [TBL] [Abstract][Full Text] [Related]
49. Turnover of neutrophils mediated by Fas ligand drives Leishmania major infection. Ribeiro-Gomes FL; Moniz-de-Souza MC; Borges VM; Nunes MP; Mantuano-Barradas M; D'Avila H; Bozza PT; Calich VL; DosReis GA J Infect Dis; 2005 Sep; 192(6):1127-34. PubMed ID: 16107969 [TBL] [Abstract][Full Text] [Related]
50. Calcineurin is required for Leishmania major stress response pathways and for virulence in the mammalian host. Naderer T; Dandash O; McConville MJ Mol Microbiol; 2011 Apr; 80(2):471-80. PubMed ID: 21320183 [TBL] [Abstract][Full Text] [Related]
51. The influence of glutathione modulators on the course of Leishmania major infection in susceptible and resistant mice. Cruz KK; Fonseca SG; Monteiro MC; Silva OS; Andrade VM; Cunha FQ; Romão PR Parasite Immunol; 2008 Mar; 30(3):171-4. PubMed ID: 18251971 [TBL] [Abstract][Full Text] [Related]
52. Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae. Azizi H; Hassani K; Taslimi Y; Najafabadi HS; Papadopoulou B; Rafati S Parasitology; 2009 Jun; 136(7):723-35. PubMed ID: 19416551 [TBL] [Abstract][Full Text] [Related]
53. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production. Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861 [TBL] [Abstract][Full Text] [Related]
54. Leishmania major: low infection dose causes short-lived hyperalgesia and cytokines upregulation in mice. Karam MC; Hamdan HG; Abi Chedid NA; Bodman-Smith KB; Eales-Reynolds LJ; Baroody GM Exp Parasitol; 2006 Jul; 113(3):168-73. PubMed ID: 16516198 [TBL] [Abstract][Full Text] [Related]
55. Mast cell degranulation contributes to susceptibility to Leishmania major. Romão PR; Da Costa Santiago H; Ramos CD; De Oliveira CF; Monteiro MC; De Queiroz Cunha F; Vieira LQ Parasite Immunol; 2009 Mar; 31(3):140-6. PubMed ID: 19222785 [TBL] [Abstract][Full Text] [Related]
56. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite. Menon JN; Bretscher PA Eur J Immunol; 1998 Dec; 28(12):4020-8. PubMed ID: 9862338 [TBL] [Abstract][Full Text] [Related]
57. Splenectomy does not interfere with immune response to Leishmania major infection in mice. Maioli TU; Carneiro CM; Assis FA; Faria AM Cell Immunol; 2007 Sep; 249(1):1-7. PubMed ID: 18093575 [TBL] [Abstract][Full Text] [Related]
58. Regulatory T cells: mediating compromises between host and parasite. Sakaguchi S Nat Immunol; 2003 Jan; 4(1):10-1. PubMed ID: 12496970 [No Abstract] [Full Text] [Related]
59. Inbred strains derived from feral mice reveal new pathogenic mechanisms of experimental leishmaniasis due to Leishmania major. Babay BE; Louzir H; Kebaïer C; Boubaker S; Dellagi K; Cazenave PA Infect Immun; 2004 Aug; 72(8):4603-11. PubMed ID: 15271920 [TBL] [Abstract][Full Text] [Related]
60. The scavenger receptor MARCO is involved in Leishmania major infection by CBA/J macrophages. Gomes IN; Palma LC; Campos GO; Lima JG; DE Almeida TF; DE Menezes JP; Ferreira CA; Santos RR; Buck GA; Manque PA; Ozaki LS; Probst CM; DE Freitas LA; Krieger MA; Veras PS Parasite Immunol; 2009 Apr; 31(4):188-98. PubMed ID: 19292770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]